Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma

Hematology/oncology Clinics of North America
Shanmugarajah Rajendra, Prateek Sharma

Abstract

Barrett esophagus (BE) is a precursor lesion for esophageal adenocarcinoma (EAC). Developments in imaging and molecular markers, and endoscopic eradication therapy, are available to curb the increase of EAC. Endoscopic surveillance is recommended, despite lack of data. The cancer risk gets progressively downgraded, raising questions about the understanding of risk factors and molecular biology involved. Recent data point to at least 2 carcinogenic pathways operating in EAC. The use of p53 overexpression and high-risk human papillomavirus may represent the best chance to detect progressors. Genome-wide technology may provide molecular signatures to aid diagnosis and risk stratification in BE.

Citations

Jan 23, 2019·International Journal of Computer Assisted Radiology and Surgery·Noha GhatwaryXujiong Ye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Related Papers

Current Treatment Options in Gastroenterology
Shanmugarajah Rajendra, Prateek Sharma
The American Journal of Gastroenterology
Pieter J F de JongePeter D Siersema
© 2022 Meta ULC. All rights reserved